fda removes semaglutide from shortage list Proposes Ban on Bulk Compounding for Semaglutide, Tirzepatide, and Liraglutide Cheap, compounded versions of Ozempic,

Nausea after eating is a common side effect of semaglutide and other GLP-1 medications, affecting up to 40% of users in clinical trials

#ASCO #PublicHealth #WomenInMedicine #DiabetesCare #CancerResearch

GLP is a 30- or 31- amino acid peptide hormone, it is deriving from the tissue-specific post-translational processing.

Semaglutide can support modest weight loss goals like 15 pounds, but outcomes depend on starting dose, treatment duration, lifestyle factors, and individual genetic predispositions in GLP-1 receptor pathways

The prevalence of type 2 diabetes (T2D) is increasing worldwide

A recently published study found that social judgments extend beyond whether you lose weight or not, but also to how you do it.